Poland· PL-100451267

Pelafen MED

A medicinal product containing pelargonii radicis tinctura, registered in Poland by Phytopharm Klęka S.A..

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedPelafen MEDATC—REGISTER NO.PL-100451267PACKS LISTED2CHECKEDSeptember 27, 2026

The record

At a glance

URPL (Poland)
Active substance
Pelargonii radicis tinctura
Manufacturer
Phytopharm Klęka S.A.
Country
Poland (PL)
ATC code
—
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 2

  • gtin
    05909991490485
  • gtin
    05909991490492

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d3e79e50-f1a9-40ea-9d66-83cd78c82139
GET /v1/drugs/d3e79e50-f1a9-40ea-9d66-83cd78c82139?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Krople doustne, roztwór",
  "source": "urpl",
  "strength": "0,8 g/ml",
  "packaging": "05909991490485 ¦ OTC ¦ 145981\n1 butelka 20 ml\n05909991490492 ¦ OTC ¦ 145982\n1 butelka 50 ml",
  "substance": "Pelargonii radicis tinctura (1: 8-10), extrahendum solvens: ethanolum 15% (v/v) 0.8 g/ml",
  "common_name": "Pelargonii radicis tinctura",
  "pl_product_id": "100451267",
  "pozwolenie_nr": "27281",
  "auth_procedure": "DCP",
  "authorisation_validity": "Bezterminowe"
}

See everything about pelargonii radicis tinctura.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.